Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Chronic sildenafil improves clinical outcomes in heart failure patients

Dec. 1, 2009

Proacta reports data on its novel hypoxia-activated pan-HER inhibitor

Dec. 1, 2009

S*BIO presents its novel, potent dual PI3K/mTOR inhibitor SB-2312

Dec. 1, 2009

Novel 2,3-dioxygenase inhibitor disclosed by Incyte for cancer immunotherapy

Dec. 1, 2009

Preclinical characterization of RP-1040 disclosed at 2009 AACR-NCI-EORTC meeting

Nov. 30, 2009

GW-876008 improves stress-induced rectal hypersensitivity in patients with IBS

Nov. 30, 2009

ICOVIR-17 adenovirus displays enhanced intratumoral distribution and activity in vivo

Nov. 30, 2009

Antimalaria vaccine elicits functional antibodies in phase I trial in malaria-naive subjects

Nov. 30, 2009

Cytokinetics discloses preclinical data on novel smooth muscle myosin inhibitors

Nov. 30, 2009

Aflibercept shows promise in phase II trial in metastatic melanoma patients

Nov. 27, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...